CD8A and hepatocellular carcinoma: Conversely, one study found that, in recurrent hepatocellular carcinoma, CD8+ T cells overexpress CD161 and show an innate hypocytotoxic state with low clonal amplification, and that enrichment of these cells is associated with a worse prognosis [35].